44.42
price down icon2.35%   -1.07
after-market 시간 외 거래: 44.52 0.10 +0.23%
loading
전일 마감가:
$45.49
열려 있는:
$45.56
하루 거래량:
1.44M
Relative Volume:
0.67
시가총액:
$5.50B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-10.48
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
-4.39%
1개월 성능:
-10.98%
6개월 성능:
-5.91%
1년 성능:
+39.12%
1일 변동 폭
Value
$44.30
$45.56
1주일 범위
Value
$44.30
$47.00
52주 변동 폭
Value
$20.14
$53.42

가든트헬스 Stock (GH) Company Profile

Name
명칭
Guardant Health Inc
Name
전화
855-698-8887
Name
주소
3100 HANOVER STREET, PALO ALTO
Name
직원
2,021
Name
트위터
@guardanthealth
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GH's Discussions on Twitter

GH을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
GH
Guardant Health Inc
44.42 5.64B 692.26M -512.41M -274.36M -4.24
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
478.32 179.32B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
205.48 145.22B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
565.19 44.23B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
199.17 34.14B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.18 34.19B 6.63B 1.17B 1.19B 4.05

가든트헬스 Stock (GH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-10 개시 Mizuho Outperform
2025-01-23 개시 Barclays Overweight
2024-06-28 업그레이드 Guggenheim Neutral → Buy
2024-06-03 재개 Jefferies Buy
2024-04-24 재개 Craig Hallum Buy
2023-12-14 개시 Guggenheim Neutral
2023-12-13 개시 Wolfe Research Peer Perform
2023-11-13 업그레이드 Raymond James Mkt Perform → Outperform
2023-09-28 개시 Bernstein Outperform
2023-09-27 업그레이드 Piper Sandler Neutral → Overweight
2023-07-05 재개 JP Morgan Overweight
2023-05-26 업그레이드 Citigroup Neutral → Buy
2023-05-05 개시 UBS Buy
2023-03-09 다운그레이드 Citigroup Buy → Neutral
2023-01-05 개시 Scotiabank Sector Outperform
2022-11-01 다운그레이드 Piper Sandler Overweight → Neutral
2022-10-19 개시 Craig Hallum Buy
2022-10-06 개시 Stephens Overweight
2022-08-25 개시 Credit Suisse Outperform
2022-06-03 개시 Piper Sandler Overweight
2022-04-28 재개 BTIG Research Buy
2022-02-24 재확인 Canaccord Genuity Buy
2022-02-24 재확인 Citigroup Buy
2022-02-24 재확인 Cowen Outperform
2022-02-24 재확인 Morgan Stanley Overweight
2022-02-24 재확인 SVB Leerink Outperform
2022-02-24 재확인 Stifel Buy
2022-02-24 재확인 Wells Fargo Overweight
2021-10-15 재개 Cowen Outperform
2021-06-15 개시 Raymond James Mkt Perform
2021-06-03 개시 Goldman Buy
2021-05-25 개시 Wells Fargo Overweight
2021-01-11 개시 Stifel Buy
2020-09-09 개시 Morgan Stanley Overweight
2020-06-12 개시 BTIG Research Buy
2020-02-21 개시 Guggenheim Buy
2020-01-07 개시 Citigroup Buy
2019-08-07 재확인 Canaccord Genuity Buy
2019-04-16 개시 Canaccord Genuity Buy
2019-04-10 업그레이드 BofA/Merrill Neutral → Buy
2019-02-28 재확인 BofA/Merrill Neutral
2018-10-29 개시 BofA/Merrill Neutral
2018-10-29 개시 JP Morgan Overweight
2018-10-29 개시 William Blair Outperform
모두보기

가든트헬스 주식(GH)의 최신 뉴스

pulisher
12:55 PM

What institutional investors are buying Guardant Health Inc. stockUnprecedented market success - jammulinksnews.com

12:55 PM
pulisher
11:25 AM

What catalysts could drive Guardant Health Inc. stock higher in 2025Lightning-fast growth - jammulinksnews.com

11:25 AM
pulisher
10:38 AM

What are Guardant Health Inc. company’s key revenue driversCapitalize on emerging market sectors - jammulinksnews.com

10:38 AM
pulisher
05:28 AM

What are the latest earnings results for Guardant Health Inc.Maximize returns with timely market signals - jammulinksnews.com

05:28 AM
pulisher
Jul 26, 2025

What makes Guardant Health Inc. stock price move sharplyCapital Safe Stock Watchlist - Metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga

Jul 26, 2025
pulisher
Jul 25, 2025

Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Guardant Health Inc. stock priceConsistent wealth multiplication - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem - GlobeNewswire Inc.

Jul 25, 2025
pulisher
Jul 25, 2025

Is Guardant Health Inc. a good long term investmentDynamic growth stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

1 Healthcare Stock with Solid Fundamentals and 2 We Avoid - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Guardant Health Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

10 Best Mid Cap Pharma Stocks to Buy - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut. - Business Insider

Jul 23, 2025
pulisher
Jul 23, 2025

Guardant Health (NASDAQ:GH investor five-year losses grow to 44% as the stock sheds US$228m this past week - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Guardant Health Inc. Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

Cathie Wood’s ARK ETFs shift focus, buying NVIDIA and selling GUARDANT - Investing.com

Jul 22, 2025
pulisher
Jul 21, 2025

Freenome's new CEO is ready to compete in race for tests that can detect cancer early - The Business Journals

Jul 21, 2025
pulisher
Jul 19, 2025

Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - Benzinga

Jul 19, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health Director Sells 142 Shares at $48.2 Per Share on 2025-07-17. - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Lung Cancer Diagnostics Market Expansion Driven by Liquid - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

(GH) Technical Data - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 15, 2025

User - FinancialContent

Jul 15, 2025
pulisher
Jul 15, 2025

Evercore ISI Keeps Their Buy Rating on Guardant Health (GH) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - BioSpace

Jul 15, 2025
pulisher
Jul 14, 2025

Guardant Health stock price target maintained at $60 by Evercore ISI - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Press Release: Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - 富途牛牛

Jul 14, 2025

가든트헬스 (GH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research WAT
$302.95
price up icon 1.50%
diagnostics_research DGX
$168.55
price down icon 1.95%
$138.90
price down icon 1.53%
diagnostics_research LH
$264.96
price down icon 1.02%
diagnostics_research MTD
$1,263.99
price up icon 0.26%
diagnostics_research A
$120.18
price down icon 0.14%
자본화:     |  볼륨(24시간):